Driven by growing volumes of diagnostic examinations and widening applications, the world market for imaging contrast agents is projected to reach $14 billion by 2015.
The forecast from market research group Global Industry Analysts targets developing countries, specifically India and China, as burgeoning regions of growth in the contrast market, particularly in light of economic growth.
Even with a lackluster global economy and its impact on the imaging equipment market, the report noted, the effect on imaging agents has been less severe, due primarily to the wide availability of existing equipment in key markets, including Europe and the U.S., and increased emphasis on diagnostic exams for the early identification of disease and subsequent treatment.
The U.S. is the largest market for imaging contrast worldwide, accounting for an estimated 40% share of the global market, followed by Japan and Europe.
Related Reading
Global DR market to reach $743M by 2015, September 13, 2010
Report projects European breast biopsy growth, February 23, 2010
U.K. cancer survival rates, spending lag Europe, February 18, 2010
European nuke med market could triple, January 25, 2010
European cancer rates declining, report indicates, January 7, 2010
Copyright © 2010 AuntMinnie.com
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&fit=crop&h=100&q=70&w=100)
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
